Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Radtke, Kerstin; * | Ettinger, Max | Heidgen, Henrik | Floerkemeier, Thilo | Noll, Yvonne | Stukenborg-Colsman, Christina | Windhagen, Henning | von Lewinski, Gabriela
Affiliations: Department of Orthopedic Surgery, Hannover Medical School, Hannover, Germany
Correspondence: [*] Corresponding author: Kerstin Radtke, Hannover Medical School (MHH), Department of Orthopedic Surgery, Anna-von-Borries-Str. 1-7, D-30625 Hannover, Germany. Tel.: +49 511 5354 847; Fax: +49 511 5354 682; E-mail: Kerstin.radtke@ddh-gruppe.de.
Abstract: Background:Resurfacing Arthroplasty (RA) of the hip has undergone resurgence with initially mainly good clinical results in young patients. It was mainly performed in younger more active patients with severe symptomatic arthritis of the hip including pelvic deformity. Furthermore the proximal femoral anatomy was preserved for surgical procedures in the future. Objective:The aim of the study was to perform a prospective review of the very first 85 hips that had implantation of one cementless resurfacing system and a mean follow up of 5 years. Methods:85 cementless Total Hip Resurfacing devices have been performed in 75 patients in our orthopaedic department. The mean age of the study group was 49.8 years. Harries Hip Score, clinical examination data and radiographic parameters including the neck shaft angle (NSA), stem shaft angle (SSA) and detection of radiolucencies were analyzed. Results:Estimated implant survival at five years of follow-up was 88.2% at 5 years follow-up using revision for all causes as the end point. Mean HHS was 92.5 (range 80–100) five years after Resurfacing Arthroplasty. Conclusions:In conclusion we have to admit, that there was a high proportion of failed hip resurfacings but in the proportion that succeeded we saw good clinical results.
Keywords: Total hip resurfacing, Resurfacing Arthroplasty (RA), clinical results
DOI: 10.3233/THC-140820
Journal: Technology and Health Care, vol. 22, no. 2, pp. 263-272, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl